| [1] |
熊志勇，姚志成，邓美海．间充质干细胞在终末期肝病及原发性肝癌中的应用[J/CD]．中华肝脏外科手术学电子杂志，2014，3(5): 322-324.
|
| [2] |
Zhou Y, Zuo D, Wang M, et al. Effect of truncated neurokinin-1 receptor expression changes on the interaction between human breast cancer and bone marrow-derived mesenchymal stem cells[J]. Genes Cells, 2014, 19(9):676-691.
|
| [3] |
Yan XL, Fu CJ, Chen L, et al. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway[J]. Breast Cancer Res Treat, 2012, 132(1):153-164.
|
| [4] |
Lin JT, Wang JY, Chen MK, et al. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6[J]. Exp Cell Res, 2013, 319(14): 2216-2229.
|
| [5] |
Lis R, Touboul C, Mirshahi P, et al. Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12[J]. Int J Cancer, 2011, 128(3):715-725.
|
| [6] |
Yan XL, Jia YL, Chen L, et al. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis[J]. Hepatology, 2013, 57(6):2274-2286.
|
| [7] |
邬杰忠，邓美海， 钟跃思，等．骨髓和肝癌来源间充质干细胞对肝癌细胞HepG2增殖、侵袭能力的影响[J]．中华实验外科杂志，2015，32(3):499-501.
|
| [8] |
Rhodes LV, Antoon JW, Muir SE, et al. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk[J]. Mol Cancer, 2010(9):295.
|
| [9] |
Kim SH, Bang SH, Kang SY, et al. Human amniotic membrane-derived stromal cells (hAMSC) interact depending on breast cancer cell type through secreted molecules[J]. Tissue Cell, 2015, 47(1):10-16.
|
| [10] |
Halpern JL, Kilbarger A, Lynch CC. Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor[J]. Cancer Lett, 2011, 308(1):91-99.
|
| [11] |
Allami RH, Graf C, Martchenko K, et al. Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues[J]. Oncol Lett, 2016, 11(3):1873-1878.
|
| [12] |
Sugihara H, Ishimoto T, Yasuda T, et al. Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction[J]. Med Oncol, 2015, 32(6):618.
|
| [13] |
Yang DL, Xin MM, Wang JS, et al. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer[J]. Genet Mol Res, 2015, 14(4):17699-17707.
|
| [14] |
Izumi D, Ishimoto T, Miyake K, et al. CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer[J]. Int J Cancer, 2016, 138(5):1207-1219.
|
| [15] |
Yamada K, Maishi N, Akiyama K, et al. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property[J]. Int J Cancer, 2015, 137(12):2825-2836.
|
| [16] |
Wu W, Qian L, Chen X, et al. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer[J]. Int J Clin Exp Pathol, 2015, 8(10):13217-13224.
|
| [17] |
do Carmo A, Patricio I, Cruz MT, et al. CXCL12/CXCR4 promotes motility and proliferation of glioma cells[J]. Cancer Biol Ther, 2010, 9(1):56-65.
|
| [18] |
Sutton A, Friand V, Brulé-Donneger S, et al. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion[J]. Mol Cancer Res, 2007, 5(1):21-33.
|
| [19] |
Alagia A, Eritja R. siRNA and RNAi optimization[J]. Wiley Interdiscip Rev RNA, 2016, 7(3):316-329.
|
| [20] |
Varshosaz J, Taymouri S. Hollow inorganic nanoparticles as efficient carriers for siRNA delivery: a comprehensive review[J]. Curr Pharm Des, 2015, 21(29): 4310-4328.
|
| [21] |
Fujita T, Yanagihara K, Takeshita F, et al. Intraperitoneal delivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice[J]. Cancer Sci, 2013, 104(2):214-222.
|